| 王申捷 孙凡 朱亮.选择性5-羟色胺再摄取抑制剂的临床应用进展[J].,2014,14(3):571-574 |
| 选择性5-羟色胺再摄取抑制剂的临床应用进展 |
| Clinical Application Progress of SSRIs |
| |
| DOI： |
| 中文关键词: 5-羟色胺 SSRIs 氟西汀 抑郁症 抗抑郁药 |
| 英文关键词: 5-HT SSRIs Fluoxetine Depression Antidepressant |
| 基金项目:上海市自然科学基金项目（12ZR1415700）；上海市重点学科开放课题（S30201）；
国家“重大新药创制”科技重大专项（2009ZX09301-007） |
|
| 摘要点击次数: 651 |
| 全文下载次数: 1104 |
| 中文摘要: |
| 5- 羟色胺(5-hydroxy tryptamine, 5-HT)是中枢及外周神经系统中一种重要的神经递质。5- 羟色胺转运体(5-HT transporter,
5-HTT)可将5-HT再摄取，降低细胞外5-HT 浓度，从而调节神经信号传导。5-HTT 异常在某些精神疾病的发病中起重要作用。近
年来选择性5- 羟色胺再摄取抑制剂(selective serotonin reuptake inhibitors, SSRIs)在临床上的应用日趋广泛，如治疗抑郁症、焦虑
症、抑郁和焦虑共病等常见的精神疾病。氟西汀、帕罗西汀、舍曲林、氟伏沙明和西酞普兰是目前临床上最常用的五种SSRIs，被誉
为抗抑郁药的“五朵金花”。本文详细介绍近年来在临床上药物治疗抑郁症取得的成果以及这类药物的药效学、药动学、不良反应
和相互作用等，并简要介绍SSRIs 在其它疾病领域取得的应用进展。 |
| 英文摘要: |
| 5-HT is an important neurotransmitter in the central and peripheral nervous system. 5-HTT can reuptake 5-HT and
reduce its extracellular concentration. Researchers have found that 5-HT anomaly playsan important role in the etiologies of some mental
illnesses. The clinical applications of SSRIs have been increasingly widespread these years, such as depression, anxiety disorder, panic
disorder, etc. Fluoxetine, Paroxetine, Sertraline, Fluvoxamine, Citalopram are the most popular medicines against depression. This article
introduces the achievements of SSRIsand their pharmacodynamics, pharmacokinetics, side effects and interactions. The progress of the
treatments of other diseasesusing SSRIs is also included. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
